Value of Collaborative Care in Major Depressive Disorder

As part of our dedication to providing you leading insights in disease management, Otsuka Pharmaceutical Development & Commercialization, Inc. is pleased to offer Frameworks in Health and Quality: Value of Collaborative Care in Major Depressive Disorder.

Cardiovascular disease, diabetes, and cancer are common in patients with MDD and may negatively impact outcomes and contribute to higher health expenditures in this patient population. In the primary care setting, PCPs, who deliver the majority of care for patients with MDD, only identify about 50 percent of MDD cases. The implementation of a collaborative care model is one way to help ensure that adequate systems are in place for efficient diagnosis, treatment, and follow-up for patients with depressive disorders.

This program is a series of unbranded resources for health care stakeholders, including payers and providers, that aims to improve understanding of MDD and collaborative care models in support of treatment goals.

Patients with MDD are often undiagnosed, undertreated, or treatment resistant, representing a significant unmet need in treatment.

Program objectives:

  • Emphasize the importance of collaborative care
  • Enhance communication among all stakeholders
  • Support stakeholders with patient and caregiver educational materials
  • Emphasize patient wellness and adherence to treatment plans
  • Promote depression management, utilization of depression screening tools, appropriate referral to a mental health specialist, and quality measures

This disease management program supports payers, providers, patients, and caregivers.


Program introductory materials and key issues for payers including Health care Effectiveness Data and Information Set (HEDIS®) quality improvement resources and disease management program components

Click here to view these resources.

Health Care Providers

Program introductory materials and education and awareness resources for providers—including primary care providers, mental health specialists, and case managers/psychiatric social workers—include disease education and awareness of MDD and comorbid medical conditions and principles of collaborative care and implementation considerations.

Click here to view these resources.

MDD is about 3 times more common among patients with diabetes than among the population at large.

Patients* and Caregivers

Health care professionals may choose to share program materials with patients and their caregivers. MDD resources for patients and caregivers focus on disease education and awareness, treatment adherence, and coping strategies. All patient and caregiver resources are also available in Spanish.

Click here to view these resources.

Collaborative Care and MDD

Evidence supports collaborative care for improving depression symptoms, adherence to treatment, response to treatment, and remission and recovery from depression. Our Frameworks in Health and Quality: Value of Collaborative Care in Major Depressive Disorder disease management program can complement your efforts by providing resources to key stakeholders who are in a position to help improve the quality of care delivered to patients.

*Frameworks resources use patient and consumer interchangeably.

Frameworks resources are intended for educational purposes only and are intended for health care professionals and/or payer representatives who may choose to share some of these resources with patients or their caregivers. Health care professionals should use independent medical judgment when considering Frameworks educational resources. Patients and caregivers should discuss Frameworks materials with a health care professional. They are not intended as, nor are they a replacement for, medical advice and treatment from a health care professional. Frameworks resources are not intended as reimbursement or legal advice. Users should seek independent, qualified professional advice to ensure their organization is in compliance with the complex legal and regulatory requirements governing health care services, and that treatment decisions are made consistent with the applicable standards of care. Frameworks is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.